A robust increase in expression of arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 273-283

  Kodama, Masafumi ^a   Akiyama, Kazufumi ^a   Ujike, Hiroshi ^a   Shimizu, Yoshio ^a,b   Tanaka, Yuji ^a   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Okayama Prefectural Okayama Hospital   (Japan)

Author keywords

Activity regulated cytoskeleton associated protein; Behavioral sensitization; In situ hybridization; Methamphetamine; MK 801; SCH23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; METHAMPHETAMINE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; GENE EXPRESSION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BLOTTING, NORTHERN; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOSKELETAL PROTEINS; DIZOCILPINE MALEATE; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; IN SITU HYBRIDIZATION; MALE; METHAMPHETAMINE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0032526870     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00349-7     Document Type: Article

References (30)

1. Akiyama K., Kanzaki A., Tsuchida K., Ujike H. Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophr. Res. 12:1994;251-257.
2. Ariano M.A., Larson E.R., Noblett K.L., Sibley D.R., Levine M.S. Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits. Synapse. 26:1997;400-414.
3. Fosnaugh J.S., Bhat R.V., Yamagata K., Worley P.F., Baraban J.M. Activation of arc a putative 'effector' immediate early gene, by cocaine in rat brain. J. Neurochem. 64:1995;2377-2380.
4. Gaspar P., Bloch B., Le Moine C. D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur. J. Neurosci. 7:1995;1050-1063.
5. Gelot A., Moreau J., Khrestchatisky M., Ben Ari Y., Pollard H. Developmental change of α-spectrin mRNA in the rat brain. Dev. Brain Res. 81:1994;240-246.
6. Hashimoto K., Minabe Y., Iyo M. Expression of cyclooxygenase-2 mRNA in rat retrosplenial cortex following administration of phencyclidine. Brain Res. 762:1997;259-263.
7. Huang Q., Zhou D., Chase K., Gusella J.F., Aronin N., DiFiglia M. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11988-11992.
8. Ishihara T., Akiyama K., Kashihara K., Ujike H., Hamamura T., Okada S., Kuroda S. Activator protein-1 binding activities in discrete regions of rat brain after acute and chronic administration of methamphetamine. J. Neurochem. 67:1996;708-716.
9. Karler R., Bedingfield J.B., Thai D.K., Calder L.D. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res. 757:1997;228-235.
10. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
11. Link W., Konietzko U., Kauselmann G., Krug M., Schwanke B., Frey U., Kuhl D. Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5734-5738.
12. Lyford G.L., Yamagata K., Kaufmann W.E., Barnes C.A., Sanders L.K., Copeland N.G., Gilbert D.J., Jenkins N.A., Lanahan A.A., Worley P.F. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron. 14:1995;433-445.
13. Maisonneuve I.M., Keller R.W., Glick S.D. Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res. 535:1990;221-226.
14. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
15. Nye H.E., Hope B.T., Kelz M.B., Iadarola M., Nestler E.J. Pharmacological studies of the regulation of chronic Fos-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275:1995;1671-1680.
16. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
17. Qian Z., Gilbert M.E., Colicos M.A., Kandel E.R., Kuhl D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature. 361:1993;453-457.
18. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
19. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:1997;8491-8497.
20. Rudolf G.D., Cronin C.A., Landwehrmeyer G.B., Standaert D.G., Penney J.B. Jr., Young A.B. Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat. Neuroscience. 73:1996;417-427.
21. Sato M., Chen C.C., Akiyama K., Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol. Psychiatry. 18:1983;429-440.
22. Stewart J., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology. 110:1993;125-132.
23. Tatetsu S. Methamphetamine psychosis. Folia Psychiatry Neurol. Jpn. Suppl. 7:1963;377-380.
24. Tong Z.-Y., Overton P.G., Clark D. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat. Brain Res. 674:1995;63-74.
25. Ujike H., Onoue T., Akiyama K., Hamamura T., Otsuki S. Effects of selective D1 and D2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology. 98:1989;89-92.
26. Vincent S.L., Khan Y., Benes F.M. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J. Neurosci. 13:1993;2551-2564.
27. Wang J.Q., McGinty J.F. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced upregulation of zif/268 mRNA expression in rat forebrain. J. Neurochem. 65:1995;2706-2715.
28. Wang J.Q., Daunais J.B., McGinty J.F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 18:1994;343-353.
29. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.
30. Yamagata K., Sanders L.K., Kaufmann W.E., Barnes C.A., Nathans D., Worley P.F. Rheb, a growth factor and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 269:1994;16333-16339.